StemPoint Capital LP 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:01 pm Purchase | 2024-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | StemPoint Capital LP | 2,328,492 8.200% | 538,310 (+30.07%) | Filing |
| 2024-02-12 6:27 pm Purchase | 2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | StemPoint Capital LP | 1,790,182 6.500% | 1,790,182 (New Position) | Filing |